Furthermore, Oue et al. showed that REG4 immunostaining associated with tumor grade, liver metastasis and poor survival, and that serum REG4 levels were increased in stage IV, but not stage I–III, CRC patients, when compared with 151 healthy controls [13]. The gene discussed is REG4; the disease is neoplasm.